Trials / Completed
CompletedNCT01365351
Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON
Non-interventional Study With ZOMACTON in Children With Growth Hormone Deficiency
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,034 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate long-term treatment with Zomacton® for pituitary short stature in children with insufficient growth hormone production and/or short stature caused by Turner syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Growth hormone | Drug given by prescription |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2016-06-01
- Completion
- 2016-06-01
- First posted
- 2011-06-03
- Last updated
- 2017-06-02
Locations
59 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01365351. Inclusion in this directory is not an endorsement.